FI962639A0 - Diaryyli-5,6-fuusioituneita heterosyklisiä happoja leukotrieeniantagonisteina - Google Patents

Diaryyli-5,6-fuusioituneita heterosyklisiä happoja leukotrieeniantagonisteina

Info

Publication number
FI962639A0
FI962639A0 FI962639A FI962639A FI962639A0 FI 962639 A0 FI962639 A0 FI 962639A0 FI 962639 A FI962639 A FI 962639A FI 962639 A FI962639 A FI 962639A FI 962639 A0 FI962639 A0 FI 962639A0
Authority
FI
Finland
Prior art keywords
diaryl
fused heterocyclic
leukotriene antagonists
heterocyclic acids
acids
Prior art date
Application number
FI962639A
Other languages
English (en)
Swedish (sv)
Other versions
FI962639A (fi
Inventor
Robert N Young
Marc Labelle
Yves Leblanc
Cheuk K Lau
Claude Dufresne
Yves Gareau
Yi Bin Xiang
Original Assignee
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada Inc filed Critical Merck Frosst Canada Inc
Publication of FI962639A publication Critical patent/FI962639A/fi
Publication of FI962639A0 publication Critical patent/FI962639A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI962639A 1993-12-28 1996-06-26 Diaryyli-5,6-fuusioituneita heterosyklisiä happoja leukotrieeniantagonisteina FI962639A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17493793A 1993-12-28 1993-12-28
US08/260,592 US5472964A (en) 1992-12-22 1994-06-16 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
PCT/CA1994/000716 WO1995018132A1 (en) 1993-12-28 1994-12-22 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists

Publications (2)

Publication Number Publication Date
FI962639A FI962639A (fi) 1996-06-26
FI962639A0 true FI962639A0 (fi) 1996-06-26

Family

ID=26870689

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962639A FI962639A0 (fi) 1993-12-28 1996-06-26 Diaryyli-5,6-fuusioituneita heterosyklisiä happoja leukotrieeniantagonisteina

Country Status (12)

Country Link
US (1) US5472964A (fi)
EP (1) EP0737196A1 (fi)
JP (1) JP3594603B2 (fi)
CN (1) CN1148389A (fi)
AU (1) AU684884B2 (fi)
CA (1) CA2180014A1 (fi)
CZ (1) CZ187996A3 (fi)
FI (1) FI962639A0 (fi)
HU (1) HUT76544A (fi)
NO (1) NO962717D0 (fi)
SK (1) SK83896A3 (fi)
WO (1) WO1995018132A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656638A (en) * 1995-04-18 1997-08-12 Geron Corporation Telomerase inhibitors
AU732671B2 (en) * 1996-02-08 2001-04-26 Merck & Co., Inc. Method of treatment and pharmaceutical composition
US6262066B1 (en) 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
EP1321169A1 (en) * 2001-12-18 2003-06-25 Biofrontera Pharmaceuticals AG Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament
CA2371048C (en) 2002-02-06 2011-01-04 Delmar Chemicals Inc. Process for the preparation of 1-(mercaptomethyl)-cyclopropaneacetic acid
WO2006017505A2 (en) * 2004-08-04 2006-02-16 Schering Corporation Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
US20060110449A1 (en) 2004-10-25 2006-05-25 Lorber Richard R Pharmaceutical composition
WO2007101841A2 (en) * 2006-03-06 2007-09-13 Farmaprojects, S. A. Process for preparing a leukotriene antagonist
BRPI0712915A2 (pt) * 2006-07-11 2012-10-09 Schering Corp sal de xinafoato de um composto de 5-oxazal-2-il-quinolina substituìdo
US20110040095A1 (en) * 2008-03-17 2011-02-17 Dr. Reddy's Laboratories Ltd. Preparation of montelukast and its salts
MX2010011154A (es) * 2008-04-11 2010-12-21 Janssen Pharmaceutica Nv Tiazolopiridin-2-iloxi-fenilo y tiazolopirazin-2-iloxifenilaminas como moduladores de la leucotrieno a4 hidrolasa.
US9532717B2 (en) * 2008-10-28 2017-01-03 The Procter & Gamble Company Method for diagnosing vulvovaginal disorders
CN102834406A (zh) 2009-06-16 2012-12-19 默沙东公司 作为糖皮质激素受体激动剂的新的[3.2-c]杂芳基甾体、其组合物和用途
CN110386888A (zh) * 2019-07-30 2019-10-29 上海红蓝医药科技有限公司 一种低成本、高收率的1-(巯甲基)环丙基乙酸生产工艺
WO2023218023A1 (en) 2022-05-13 2023-11-16 Idorsia Pharmaceuticals Ltd Thiazoloaryl-methyl substituted cyclic hydrazine-n-carboxamide derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4794188A (en) * 1982-12-01 1988-12-27 Usv Pharmaceutical Corporation Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity
CA1322005C (en) * 1987-11-25 1993-09-07 Robert N. Young Benzoheterazoles
US5026698A (en) * 1988-11-02 1991-06-25 Nissan Chemical Industries, Ltd. Thienopyridine type mevalonolactones
DE19875039I2 (de) * 1990-10-12 2003-05-22 Merck Frosst Canada Inc Ungesaettigte Hydroxyalkylchinolinsaeuren als Leukotrien-Antagonisten
CA2053216C (en) * 1990-10-12 2003-04-08 Michel L. Belley Saturated hydroxyalkylquinoline acids as leukotriene antagonists
US5308850A (en) * 1991-09-30 1994-05-03 Merck Frosst Canada, Inc. (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5506227A (en) * 1992-04-13 1996-04-09 Merck Frosst Canada, Inc. Pyridine-substituted benzyl alcohols as leukotriene antagonists
CA2111372C (en) * 1992-12-22 2007-01-16 Robert N. Young Diaryl 5,6-fusedheterocyclic acids as leukotriene antagonists

Also Published As

Publication number Publication date
HU9601772D0 (en) 1996-09-30
NO962717L (no) 1996-06-27
JPH09507080A (ja) 1997-07-15
SK83896A3 (en) 1997-02-05
JP3594603B2 (ja) 2004-12-02
CZ187996A3 (en) 1997-01-15
HUT76544A (en) 1997-09-29
US5472964A (en) 1995-12-05
CN1148389A (zh) 1997-04-23
WO1995018132A1 (en) 1995-07-06
CA2180014A1 (en) 1995-07-06
FI962639A (fi) 1996-06-26
EP0737196A1 (en) 1996-10-16
AU1378195A (en) 1995-07-17
AU684884B2 (en) 1998-01-08
NO962717D0 (no) 1996-06-27

Similar Documents

Publication Publication Date Title
ATE226578T1 (de) Benzofuranderivate als tachykininantagonisten
DE59501802D1 (de) Substituierte 1H-3-Aryl-pyrrolidin-2,4-dion-Derivate
BR9711262A (pt) Derivados 6,6 substituido hetero biciclicos
MX20359A (es) Derivados de 2-oxindol 3-substituidos.
NL300035I2 (nl) Gesubstitueerde thiazolidinedionderivaten.
MX9201823A (es) Derivados de quinolina.
KR950700304A (ko) 5ht4-수용체 길항질로서 축합 인돌 유도체(condensed indole derivatives as 5ht4-receptor antagonists)
FI962639A0 (fi) Diaryyli-5,6-fuusioituneita heterosyklisiä happoja leukotrieeniantagonisteina
FI961628A0 (fi) Indolijohdannaisia NMDA-antagonisteina
MX9204190A (es) Derivdos de 2-(4-hidroxipiperidino)-1-alcanol como agentes antiisquemicos.
FI955164A0 (fi) Heterosykliset johdannaiset
MA26543A1 (fr) Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles.
ID22838A (id) Oksazolidina sebagai antagonis 5-ht2a
FI970110A (fi) Helico-bakteerin vastaisia heterosyklisiä atsolonijohdannaisia
DE68923913D1 (de) Neplanocinderivate.
DE69106545D1 (de) Verbesserungen an Leukotrien-Antagonieten.
DE69006142D1 (de) Substituierte Glutaramidsäuren und Derivate.
ATE218564T1 (de) Pyrazol-4-yl-hetaroylderivate als herbizide
ATE325118T1 (de) Piperazinoderivate als neurokinin-antagonisten
DE69514315T2 (de) AZABICYCLOALKYLDERIVATE VON IMIDAZO[1,5-a]INDOL-3-ONE ALS 5HT3 ANTAGONISTEN
NO950684D0 (no) Nye imidazopyridinderivater som angiotensinII-antagonister
DE69013131D1 (de) 2-(2-Cyclopropylpyrrolidin-4-ylthio)carbapenemderivate.
AU7379794A (en) Aza-5,5-fused heterocyclic acids as leukotriene antagonists
FI940607A0 (fi) Imidatso(5,1-C)(1,4)bentsoksatsin-1-onijohdannaiset 5HT3-antagonisteina
DE69710921T2 (de) Heterocyclische substituierte pyrrolidinamid-derivate